Acasti Pharma, a late-stage biopharma company with drug candidates addressing rare and orphan diseases, has selected WuXi Clinical Development to conduct its STRIVE-ON phase 3 safety trial for GTX-104, a novel injectable nimodipine formulation for intravenous...
The two pharma firms will partner to study the efficacy of Opdivo, paired with a SHP2 inhibitor, to treat non-small cell lung cancer with KRAS mutations.
RedHill Biopharma has completed enrollment for its Phase II study exploring the use of opaganib in treating COVID-19 patients that have severe pneumonia.
Females as caregivers, clinical trial participants, and biopharma leaders are among the different roles to be carefully considered as the industry aims for increased inclusion, says BBK executive.
Zenith-Cognizant Technologies emerges from an acquisition aimed to streamline solutions as more complex “smart factories” become a greater focus in the biopharmaceutical industry.
Verily is aligning itself with big names in pharma to bolster its Project Baseline, designed to use digital sources to promote patient-centered clinical research programs.
Aetion aims to advance the adoption of and standards for real-world evidence backed by a strategic investment from several global biopharma and health care companies.
Pressure BioSciences has launched a commercial biopharmaceutical contract service business after acquiring a protein therapeutics platform that it says reduces challenges and manufacturing costs of the growing drug market.
Thousand Oaks Biopharmaceuticals raised $45m in Series A financing, enabling the company to expand its CDMO and CMC services as well as its capabilities in global biologics development.
The biopharmaceutical analytical and bioanalytical contract solutions provider SGS is investing more than $1.7m to expand its North American biopharmaceutical testing capabilities.
World Street Fundamentals (WSF), the financial research specialist, has released two industry reports highlighting the mixed fortunes of biotech firms Biodel and MannKind, but claims a “brighter decade” lies ahead for the biotech sector.
Germany's Rentschler Biotechnologie and Boehringer Ingelheim have
inked a preferred partnership agreement to jointly offer customers
a more streamlined biopharmaceutical production option.
A successful and strategically important year,' is how Sartorius
CEO Joachim Kreuzburg described 2007, a year highlighted
by merger of its biotechnology division with Stedim to boost its
presence in the burgeoning biopharmaceutical...
The hook-up between German and French firms Sartorius and Stedim to
create a combined biotech business is now complete, with the deal
finalised and the new company ready to roll.
US-based firm Goodwin Biotechnology said it is about to complete
the expansion of its biomanufacturing facility as the number of
contracts with biotech companies has jumped in the past two years.
Denmark's Novozymes has set up a dedicated business unit in the UK
to make and sell ingredients that support companies wanting to
produce biopharmaceuticals without using animal-derived
constituents.
Germany's Vetter Pharma-Fertigung has announced it has obtained a
manufacturing license for its new facility which will expand its
services by adding vial filling for lyophilised (freeze-dried)
products to its portfolio, in addition...
Filter maker Pall Corporation has announced its plan to invest
about $50m (€63.5m) to expand its life sciences manufacturing
operations in Puerto Rico and take advantage the island's low tax
regime.
Despite its consolidation, the competitive consumable sector still
offers potential for rapid growth and better profits in the
biopharmaceutical industry, while contract bioprocessing services
will be increasingly in demand, according...
The Netherlands has set up a programme to boost its biotechnology
sector by helping small and medium-sized biopharma firms to develop
and manufacture products, writes Phil Taylor.
Filtration and separation company Pall has made another acquisition
in the chromatography sector with the purchase of Euroflow (UK) for
an undisclosed amount.
Laborium Biopharma and the Biotechnology Research Institute of the
National Research Council (BRI-NRC) have entered into an alliance,
further boosting the biomanufacturing sector of Montreal in Quebec,
Canada.
Developer of disposable container systems Stedim has teamed up with
a Californian firm to bring to market an alternative to
conventional media kitchens, designed to reduce the costs of
biomanufacturing.
New filtration products for biopharmaceutical development and
production were unveiled at last week's Interphex 2004 exhibition
in New York by two of the main players in the sector - Pall and
Millipore.
The notion that there is undercapacity in biomanufacturing has
become common wisdom, but a new study suggest that now supply and
demand are in balance.
